查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600533

医用生物聚合物市场：按类型、来源、应用分类 - 2025-2030 年全球预测

Biopolymers for Medical Applications Market by Type (Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC), Source (Natural, Synthetic), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医用生物聚合物市场价值为24.3亿美元，预计到2024年将达到30亿美元，复合年增长率为23.24%，预计到2030年将达到105.2亿美元。

医用生物聚合物包括因其生物相容性、生物分解性和低毒性而用于各种医疗环境的天然衍生聚合物。这些材料在医疗设备、组织工程、伤口敷料、药物传递系统等方面发挥重要作用。由于对永续和环保医疗产品的需求不断增加，加上生物技术的进步，医疗领域对生物聚合物的需求不断增长。应用范围广泛，包括外科植入、药物传输系统和组织工程支架，最终用途为医院、研究机构和专科诊所。关键的成长要素包括慢性病盛行率的增加、永续实践意识的增强以及医疗应用的技术进步。此外，有利于生物基产品的法规环境正在增加市场机会。一个值得注意的机会在于使用基于生物聚合物的载体开发个人化医疗解决方案，以提供副作用最小的创新治疗方法。然而，高製造成本、有限的机械性能和严格的监管要求等挑战构成了市场成长的主要障碍。透过改善生物聚合物混合物的性能、改进生产过程以降低成本以及扩大在不太饱和的市场（例如生物分解性的整形外科植入）中的应用，可以加速创新。需要进一步研究开发具有更好机械和热性能的生物聚合物，以确保更广泛的适用性。生物聚合物市场的本质是动态的，受到不断的技术进步和不断增长的最终用户需求的推动，凸显了持续投资研发的必要性。希望利用这个快速成长市场的公司正在专注于与生物技术公司建立策略伙伴关係关係，以瞄准未开发的区域市场，最大限度地提高成长潜力并促进业务扩张。

主要市场统计
基准年[2023] 24.3亿美元
预测年份 [2024] 30亿美元
预测年份 [2030] 105.2亿美元
复合年增长率（%） 23.24%

市场动态：揭示快速发展的医用生物聚合物市场的关键市场洞察

供需的动态交互作用正在改变医用生物聚合物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 医疗设备和植入製造对生物聚合物的需求增加
    • 扩大生物聚合物在先进影像和骨骼组织特异性治疗的应用
    • 生物高分子灭菌技术的开发
  • 市场限制因素
    • 生物聚合物性能问题
  • 市场机会
    • 生物聚合物创新与永续生产
    • 奈米颗粒药物传输系统在癌症中的普及
  • 市场挑战
    • 与合成生物聚合物相关的生物相容性问题

波特五力：驾驭医用生物聚合物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对医用生物聚合物市场的外部影响

外部宏观环境因素在塑造医用生物聚合物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解医用生物聚合物市场的竞争格局

对医用生物聚合物市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵医用生物聚合物市场供应商的绩效评估

FPNV定位矩阵是评估医用生物聚合物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医疗设备和植入製造对生物聚合物的需求增加
      • 扩大生物聚合物在先进影像和骨骼组织特异性治疗的应用
      • 生物高分子灭菌技术的开发
    • 抑制因素
      • 与生物聚合物相关的性能问题
    • 机会
      • 生物聚合物创新与永续生产
      • 奈米颗粒药物传输系统在癌症中的普及
    • 任务
      • 与合成生物聚合物相关的生物相容性问题
  • 市场区隔分析
    • 类型：永续性发展的趋势集中在生物聚合物的医疗保健应用
    • 资料来源：由于生物相容性、生物功能性、机械性质、降解率和免疫抗原性的改善，合成生物聚合物的需求不断增加。
    • 应用：改良的组织生成能力扩大了在伤口伤口缝合和癒合、创伤治疗等方面的应用。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化
    • 专利分析及趋势

第六章医用生物聚合物市场：依类型

  • 生物基聚乙烯
  • 生物分解性淀粉混合物
  • 生物电脑
  • Bio-Pet
  • 生物聚氨酯
  • 纤维素衍生物
  • Pha
  • 再生纤维素

第七章医用生物聚合物市场：依来源分类

  • 自然的
  • 合成

第八章医用生物聚合物市场：依应用分类

  • 生物可吸收支架
  • 牙科
  • 药物输送系统。
  • 治疗产品
  • 手术植入装置
  • 治疗影像
  • 伤口缝合

第九章美洲医用生物聚合物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太医用生物聚合物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲医用生物聚合物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 杜邦完成对频谱 Plastics Group 的收购
    • 赛诺菲完成对 Prevention Bio, Inc. 的收购
    • 威格斯投资新的医疗设备产品开发中心和製造扩张

公司名单

  • Geistlich Pharma AG
  • Blafar Ltd.
  • GELITA AG
  • BioPolymer GmbH & Co. KG
  • Green Dot Bioplastics Inc.
  • Corbion NV
  • Evonik Industries AG
  • ITV Denkendorf Product Service GmbH
  • Thermo Fisher Scientific, Inc.
  • Danimer Scientific, Inc.
  • Toray Industries Inc.
  • Symatese
  • HyMedPoly
  • BASF SE
  • Merck & Co., Inc.
  • Tate & Lyle PLC
  • Biesterfeld AG
  • Invibio Ltd. by Victrex PLC
  • Solvay SA
  • NatureWorks LLC
  • Rodenburg Productie BV
  • SolyPlus GmbH
  • Eastman Chemical Company
  • HTL
  • DuPont de Nemours, Inc.
Product Code: MRR-435FD7709B83

The Biopolymers for Medical Applications Market was valued at USD 2.43 billion in 2023, expected to reach USD 3.00 billion in 2024, and is projected to grow at a CAGR of 23.24%, to USD 10.52 billion by 2030.

Biopolymers for medical applications encompass naturally derived polymers used in various medical settings due to their biocompatibility, biodegradable properties, and low toxicity. These materials play an essential role in medical devices, tissue engineering, wound dressing, drug delivery systems, and more. The rising necessity for biopolymers in the medical field is driven by an increasing demand for sustainable and eco-friendly medical products coupled with advances in biotechnology. Applications extend across surgical implants, drug delivery systems, and scaffolding materials for tissue engineering, while their end-use spans hospitals, research facilities, and specialized clinics. Key growth factors include the increasing prevalence of chronic diseases, heightened awareness of sustainable practices, and technological advancements in medical applications. Furthermore, the regulatory environment favoring bio-based products enhances market opportunities. A notable opportunity lies in the development of personalized medicine solutions utilizing biopolymer-based carriers for active ingredients, offering innovative treatment paths with minimized side effects. However, challenges such as high production costs, limited mechanical properties, and strict regulatory requirements pose significant barriers to market growth. Innovation can be fostered by improving biopolymer blend properties, enhancing production processes to reduce costs, and expanding applications in less saturated markets such as biodegradable orthopedic implants. Further research is needed to develop biopolymers with better mechanical and thermal properties ensuring broader application potential. The nature of the biopolymer market is dynamic, driven by constant technological advancements and increasing end-user demands, highlighting the need for continuous investment in research and development. Companies aiming to capitalize on this burgeoning market should focus on strategic partnerships with biotech firms and focus on targeting underdeveloped regional markets with tailored biopolymer products to maximize growth potential and foster business expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 2.43 billion
Estimated Year [2024] USD 3.00 billion
Forecast Year [2030] USD 10.52 billion
CAGR (%) 23.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopolymers for Medical Applications Market

The Biopolymers for Medical Applications Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
    • Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
    • Development of Sterilization Technology for Biopolymers
  • Market Restraints
    • Performance Issues Associated with the Biopolymers
  • Market Opportunities
    • Innovations and Sustainable Production of Biopolymers
    • Proliferation of Nano-Particle Drug Delivery Systems in Cancer
  • Market Challenges
    • Biocompatibility Issues Associated with Synthetic Biopolymers

Porter's Five Forces: A Strategic Tool for Navigating the Biopolymers for Medical Applications Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopolymers for Medical Applications Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopolymers for Medical Applications Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopolymers for Medical Applications Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopolymers for Medical Applications Market

A detailed market share analysis in the Biopolymers for Medical Applications Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopolymers for Medical Applications Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopolymers for Medical Applications Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Biopolymers for Medical Applications Market, highlighting leading vendors and their innovative profiles. These include Geistlich Pharma AG, Blafar Ltd., GELITA AG, BioPolymer GmbH & Co. KG, Green Dot Bioplastics Inc., Corbion NV, Evonik Industries AG, ITV Denkendorf Product Service GmbH, Thermo Fisher Scientific, Inc., Danimer Scientific, Inc., Toray Industries Inc., Symatese, HyMedPoly, BASF SE, Merck & Co., Inc., Tate & Lyle PLC, Biesterfeld AG, Invibio Ltd. by Victrex PLC, Solvay S.A., NatureWorks LLC, Rodenburg Productie B.V., SolyPlus GmbH, Eastman Chemical Company, HTL, and DuPont de Nemours, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopolymers for Medical Applications Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC, Bio-PET, Bio-PUR, Cellulose Derivatives, PHA, and Regenerated Cellulose.
  • Based on Source, market is studied across Natural and Synthetic.
  • Based on Application, market is studied across Bioresorbable Scaffolds, Dentistry, Drug Delivery Systems., Healing Products, Surgical Implant Devices, Therapeutic Imaging, and Wound Closure.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
      • 5.1.1.2. Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
      • 5.1.1.3. Development of Sterilization Technology for Biopolymers
    • 5.1.2. Restraints
      • 5.1.2.1. Performance Issues Associated with the Biopolymers
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations and Sustainable Production of Biopolymers
      • 5.1.3.2. Proliferation of Nano-Particle Drug Delivery Systems in Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Biocompatibility Issues Associated with Synthetic Biopolymers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising inclination toward the sustainability is emphasizing focus on application of biopolymers healthcare
    • 5.2.2. Source: Synthetic biopolymers are in demand due to enhanced biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity
    • 5.2.3. Application: Expandable use in drug discovery, and wound closure owing to the rising tissue generation capability
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. Patent Analysis & Trend

6. Biopolymers for Medical Applications Market, by Type

  • 6.1. Introduction
  • 6.2. Bio-Based Polyethylene
  • 6.3. Bio-degradable Starch Blends
  • 6.4. Bio-PC
  • 6.5. Bio-PET
  • 6.6. Bio-PUR
  • 6.7. Cellulose Derivatives
  • 6.8. PHA
  • 6.9. Regenerated Cellulose

7. Biopolymers for Medical Applications Market, by Source

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Biopolymers for Medical Applications Market, by Application

  • 8.1. Introduction
  • 8.2. Bioresorbable Scaffolds
  • 8.3. Dentistry
  • 8.4. Drug Delivery Systems.
  • 8.5. Healing Products
  • 8.6. Surgical Implant Devices
  • 8.7. Therapeutic Imaging
  • 8.8. Wound Closure

9. Americas Biopolymers for Medical Applications Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopolymers for Medical Applications Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopolymers for Medical Applications Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. DuPont Completes Acquisition of Spectrum Plastics Group
    • 12.3.2. Sanofi completes acquisition of Provention Bio, Inc.
    • 12.3.3. Victrex Invests In New Medical Device Product Development Centre And Manufacturing Expansion

Companies Mentioned

  • 1. Geistlich Pharma AG
  • 2. Blafar Ltd.
  • 3. GELITA AG
  • 4. BioPolymer GmbH & Co. KG
  • 5. Green Dot Bioplastics Inc.
  • 6. Corbion NV
  • 7. Evonik Industries AG
  • 8. ITV Denkendorf Product Service GmbH
  • 9. Thermo Fisher Scientific, Inc.
  • 10. Danimer Scientific, Inc.
  • 11. Toray Industries Inc.
  • 12. Symatese
  • 13. HyMedPoly
  • 14. BASF SE
  • 15. Merck & Co., Inc.
  • 16. Tate & Lyle PLC
  • 17. Biesterfeld AG
  • 18. Invibio Ltd. by Victrex PLC
  • 19. Solvay S.A.
  • 20. NatureWorks LLC
  • 21. Rodenburg Productie B.V.
  • 22. SolyPlus GmbH
  • 23. Eastman Chemical Company
  • 24. HTL
  • 25. DuPont de Nemours, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BASED POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 155. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2023